AVA Member Updates

The Australian Government has released new national veterinary guidelines on Canine ehrlichiosis (Ehrlichia canis).

Yesterday, ahead of the general notification, Australian Veterinary Association was informed of proposed changes to veterinary education at the University of Melbourne including the proposed changes to the operation of the U-Vet Animal Hospital at Werribee.

The AVA HR Advisory Service has prepared an article to flag upcoming Industrial Relations reforms.

The QLD Division President, Dr Benjamin Brightman, provides his report for the month of November.

Did you know that 43% of companion animal owners say their pet has at least one behavioural problem?

Neptra is the only single dose long-acting otic solution suitable for acute OE cases involving the most common OE causative organisms Staphylococcus pseudintermedius, Streptococcus canis and Malassezia pachydermatis. But what makes a single-dose, vet-administered solution a good first-line OE treatment choice?

Dechra Veterinary Products’ Osphos is a clodronate injection formulated to control the clinical signs associated with navicular syndrome in horses four years or older. Osphos is highly recommended for performance horses showing signs of lameness that can be attributed to navicular syndrome in particular thoroughbreds and quarter horses.  

Dr Bronwyn Orr, Dr David Andrews and Dr Mark Schipp met recently to discuss the future of the veterinary profession.

Please read this letter to all GP practices from the WA ECC Centres who are providing emergency and after hours care.

The AVA thanks VSANZ for the opportunity to comment on this important issue. Our process to inform this submission involved asking members for feedback on the specific questions and using this alongside AVA knowledgebase and policies to develop the submission.